Background: Large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of prostate cancer. The pathogenesis, clinical manifestation, treatment options, and prognosis are uncertain and underreported.
Materials And Methods: A systematic search was conducted in April 2022 through PubMed, Embase, and Cochrane.